` Comparison: 532523 vs CYTH - Alpha Spread

532523
vs
CYTH

Over the past 12 months, BIOCON has significantly outperformed CYTH, delivering a return of +27% compared to the CYTH's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
532523
CYTH
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BIOCON Intrinsic Value
431.69 INR
Undervaluation 10%
Intrinsic Value
Price
CYTH Intrinsic Value
326.76 USD
Undervaluation 70%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Biocon Ltd
BSE:532523
388.1 INR
Cyclo Therapeutics Inc
NASDAQ:CYTH
99 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
532523, CYTH

532523
CYTH
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Biocon Ltd
Revenue
Cyclo Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
532523, CYTH

532523
CYTH
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Biocon Ltd
BSE:532523
Cyclo Therapeutics Inc
NASDAQ:CYTH
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BIOCON
65.7%
CYTH
91.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Biocon Ltd
Cyclo Therapeutics Inc

Operating Margin

BIOCON
9.6%
CYTH
-2 834.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Biocon Ltd
Cyclo Therapeutics Inc

Net Margin

BIOCON
3.6%
CYTH
-2 848.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Biocon Ltd
Cyclo Therapeutics Inc

FCF Margin

BIOCON
10.7%
CYTH
-2 586.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Biocon Ltd
Cyclo Therapeutics Inc

ROE

BIOCON
2.5%
CYTH
341.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Biocon Ltd
Cyclo Therapeutics Inc

ROA

BIOCON
1%
CYTH
-457.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Biocon Ltd
Cyclo Therapeutics Inc

ROIC

BIOCON
3.1%
CYTH
1 154.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Biocon Ltd
Cyclo Therapeutics Inc

ROCE

BIOCON
3.7%
CYTH
340.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Biocon Ltd
Cyclo Therapeutics Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
532523, CYTH

Loading
532523
CYTH
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
532523, CYTH

Loading
532523
CYTH
Difference
www.alphaspread.com

Performance By Year
532523, CYTH

Loading
532523
CYTH
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 532523 to other stocks
PNEXF
Pharnext SCA
More expensive
vs BIOCON
ABBV
Abbvie Inc
More expensive
vs BIOCON
ATXS
Astria Therapeutics Inc
More expensive
vs BIOCON
AMGN
Amgen Inc
More expensive
vs BIOCON
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett